FN1 and neoplasm: Importantly, in tumor tissue, the combination therapy of Fn-OMV and oHSV effectively converted M2 tumor-associated macrophages (TAMs) into M1 phenotype (Fig. 6h and Supplementary Fig. 8a, b).